Full Paper
PAMAM Dendrimers Mediate siRNA Delivery to Target Hsp27 and Produce Potent Antiproliferative Effects on Prostate Cancer Cells
Article first published online: 16 JUN 2009
DOI: 10.1002/cmdc.200900076
Copyright © 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Additional Information
How to Cite
Liu, X.-x., Rocchi, P., Qu, F.-q., Zheng, S.-q., Liang, Z.-c., Gleave, M., Iovanna, J. and Peng, L. (2009), PAMAM Dendrimers Mediate siRNA Delivery to Target Hsp27 and Produce Potent Antiproliferative Effects on Prostate Cancer Cells. ChemMedChem, 4: 1302–1310. doi: 10.1002/cmdc.200900076
Publication History
- Issue published online: 30 JUL 2009
- Article first published online: 16 JUN 2009
- Manuscript Revised: 18 MAY 2009
- Manuscript Received: 25 FEB 2009
Funded by
- National Natural Science Foundation of China. Grant Numbers: 20572081, 20025311
- CNRS
- INSERM
- Association Française contre les Myopathies. Grant Numbers: 13074, 10793
- PPF CNP2. Grant Number: 20042462
- COST Action. Grant Number: TD0802
- Abstract
- Article
- References
- Cited By
Keywords:
- dendrimers;
- gene delivery;
- gene silencing;
- Hsp27;
- prostate cancer
Abstract
RNA interference (RNAi) holds great promise for the treatment of inherited and acquired diseases, provided that safe and efficient delivery systems are available. Herein we report that structurally flexible triethanolamine (TEA) core PAMAM dendrimers are able to deliver an Hsp27 siRNA effectively into prostate cancer (PC-3) cells by forming stable nanoparticles with siRNA, protecting the siRNA nanoparticles from enzymatic degradation, and enhancing cellular uptake of siRNA. The Hsp27 siRNA resulted in potent and specific gene silencing of heat-shock protein 27, an attractive therapeutic target in castrate-resistant prostate cancer. Silencing of the hsp27 gene led to induction of caspase-3/7-dependent apoptosis and inhibition of PC-3 cell growth in vitro. In addition, the siRNA–dendrimer complexes are non-cytotoxic under the conditions used for siRNA delivery. Altogether, TEA core PAMAM dendrimer-mediated siRNA delivery, in combination with RNAi that specifically targets Hsp27, may constitute a promising approach for combating castrate-resistant prostate cancer, for which there is no efficacious treatment.

1860-7187/asset/2452_left.gif?v=1&s=4110e7425ac5e40773dfb0778cfefa62f1594507)
1860-7187/asset/2452_right.gif?v=1&s=8458ea1f15af84217b579501ed7d7733bef04a94)
